Form 4: Molina Healthcare COO Woys Reports Stock Transactions

Molina Healthcare's Chief Operating Officer, James Woys, reported the acquisition of 17,016 restricted shares and the disposition of 1,313 shares for tax withholding purposes.

Summary

• James Woys, Chief Operating Officer of Molina Healthcare, Inc. (MOH), reported transactions involving the company's common stock.
• On March 1, 2026, 1,313 shares were disposed of at a price of $154.05 per share to cover withholding taxes related to the vesting of 5,337 shares.
• Concurrently, 17,016 restricted shares were granted under the Issuer's 2025 Equity Incentive Plan at a volume-weighted average price of $145.75.
• Following these transactions, James Woys beneficially owns 90,034 shares of common stock.
• The newly granted 17,016 shares will vest in one-third increments on March 1, 2027, March 1, 2028, and March 1, 2029.
• Additional shares will vest: 3,632 shares on March 1, 2027, and 2,082 shares on March 1, 2028.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive signal, reflecting ongoing executive incentive alignment through equity grants, which is a standard and healthy practice for public companies.

Positives

• Grant of 17,016 restricted shares to the Chief Operating Officer, indicating continued alignment of management's interests with shareholders.
• The grant is part of the company's 2025 Equity Incentive Plan, suggesting ongoing use of equity compensation to incentivize executives.

Negatives

• Disposition of 1,313 shares for tax withholding purposes, which reduces direct beneficial ownership, although this is a standard practice for vested equity.

Future Outlook

The filing details future vesting schedules for restricted stock granted to the Chief Operating Officer, with portions vesting on March 1, 2027, March 1, 2028, and March 1, 2029, indicating a long-term incentive structure.

Industry Context

StockSavvy.ai notes that equity grants to executive officers like the Chief Operating Officer are a common practice in the healthcare industry, aligning executive incentives with long-term company performance and shareholder value. This particular grant under the 2025 Equity Incentive Plan is consistent with typical executive compensation strategies seen across publicly traded healthcare providers.

Related Party Transactions

• The transactions reported involve James Woys, the Chief Operating Officer, and Molina Healthcare, Inc., which are considered related party dealings under SEC regulations for insider reporting.

Stakeholder Impact

• Shareholders: The grant of restricted stock aligns the Chief Operating Officer's interests with long-term shareholder value. The disposition for taxes is a routine event with minimal direct impact on other shareholders.
• Employees: The use of an Equity Incentive Plan suggests a broader framework for employee incentives, potentially impacting morale and retention.

Next Steps

• Vesting of one-third of the 17,016 newly granted shares on March 1, 2027.
• Vesting of 3,632 additional shares on March 1, 2027.
• Vesting of one-third of the 17,016 newly granted shares on March 1, 2028.
• Vesting of 2,082 additional shares on March 1, 2028.
• Vesting of the final one-third of the 17,016 newly granted shares on March 1, 2029.

Key Dates

Keywords

Molina Healthcare, MOH, James Woys, Chief Operating Officer, Insider Transaction, Form 4, Restricted Stock Grant, Equity Incentive Plan, Stock Vesting, Beneficial Ownership